217
Views
36
CrossRef citations to date
0
Altmetric
Original Scientific Reports

Effect of Severity of Dupuytren contracture on disability

, & , PhD , MD
Pages 41-42 | Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Arvind Mohan, Jane Vadher, Hiba Ismail & David Warwick. (2014) The Southampton Dupuytren's Scoring Scheme. Journal of Plastic Surgery and Hand Surgery 48:1, pages 28-33.
Read now
Ilse Degreef, Sabine Tejpar & Luc De Smet. (2011) Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implant. Journal of Plastic Surgery and Hand Surgery 45:3, pages 157-164.
Read now
Alexis Thomas & Ardeshir Bayat. (2010) The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease. Therapeutics and Clinical Risk Management 6, pages 557-572.
Read now

Articles from other publishers (33)

Rafael Sanjuan-Cervero, Diego Gomez-Herrero, Jaime E. Poquet-Jornet, Fernando Peña-Molina, Nicolas H. de la Iglesia, Aurora Sanjuan-Arago, Pedro Vazquez-Ferreiro & Francisco J. Carrera-Hueso. (2022) A comparison of patient-reported outcome measures for dupuytren disease: A prospective view. Journal of Plastic, Reconstructive & Aesthetic Surgery 75:10, pages 3774-3781.
Crossref
Maarten Van Nuffel, Caroline Meulyzer, Britt Gheysen, Arne Böhrer, Mieke Anthonissen, Eric Van den Kerckhove & Ilse Degreef. (2022) Palmar skin elasticity measured by the Cutometer MPA 580 is decreased in mild Dupuytren’s disease compared to healthy controls. Hand Therapy 27:1, pages 14-21.
Crossref
Bert Reichert & Wolfgang WachBert Reichert & Wolfgang Wach. 2022. Morbus Dupuytren. Morbus Dupuytren 29 39 .
James Chambers, Taylor Pate & James Calandruccio. (2020) Office-Based Percutaneous Fasciotomy for Dupuytren Contracture. Orthopedic Clinics of North America 51:3, pages 369-372.
Crossref
Ralph Poelstra, Yara E. van Kooij, Mark J. W. van der Oest, Harm P. Slijper, Steven E. R. Hovius & Ruud W. Selles. (2019) Patient’s satisfaction beyond hand function in Dupuytren’s disease: analysis of 1106 patients. Journal of Hand Surgery (European Volume) 45:3, pages 280-285.
Crossref
Anne-Gita Scheibler, Miriam Marks, Stefanie Hensler, Daniel B. Herren & Maurizio Calcagni. (2019) Factors predicting the 1-year outcome of collagenase treatment for Dupuytren’s disease. Archives of Orthopaedic and Trauma Surgery 139:4, pages 583-588.
Crossref
Jesper Nordenskjöld, Anna Lauritzson, Markus Waldén, Philippe Kopylov & Isam Atroshi. (2019) Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial. BMJ Open 9:2, pages e024424.
Crossref
R. Sanjuán-Cerveró, P. Vazquez-Ferreiro, D. Gómez-Herrero, F.J. Carrera-Hueso & N. Fikri-Banbrahim. (2018) One year follow-up after treatment with CCH for Dupuytren's contracture: A prospective view. Revista Española de Cirugía Ortopédica y Traumatología (English Edition) 62:6, pages 448-457.
Crossref
R. Sanjuán-Cerveró, P. Vazquez-Ferreiro, D. Gómez-Herrero, F.J. Carrera-Hueso & N. Fikri-Banbrahim. (2018) Evolución al año de tratamiento con CCH para la contractura de Dupuytren: estudio prospectivo. Revista Española de Cirugía Ortopédica y Traumatología 62:6, pages 448-457.
Crossref
Dieuwke C. Broekstra, Edwin R. van den Heuvel, Rosanne Lanting & Paul M. N. Werker. (2018) Measurement properties of the Dutch Unité Rhumatologique des Affections de la Main and its ability to measure change due to Dupuytren’s disease progression compared with the Michigan Hand outcomes Questionnaire. Journal of Hand Surgery (European Volume) 43:8, pages 855-863.
Crossref
José M. Arandes-Renú, Rafael Sanjuán-Cerveró & Ignacio Moya-Molinas. 2018. Collagenase in Dupuytren Disease. Collagenase in Dupuytren Disease 39 74 .
D. Warwick. (2017) Dupuytren’s disease: my personal view. Journal of Hand Surgery (European Volume) 42:7, pages 665-672.
Crossref
J. N. Rodrigues, W. Zhang, B. E. Scammell, D. Davidson, S. Fullilove, I. Chakrabarti, P. G. Russell & T. R. C. Davis. (2016) Recovery, responsiveness and interpretability of patient-reported outcome measures after surgery for Dupuytren’s disease. Journal of Hand Surgery (European Volume) 42:3, pages 301-309.
Crossref
J. N. Rodrigues, W. Zhang, B. E. Scammell, I. Chakrabarti, P. G. Russell, S. Fullilove, D. Davidson & T. R. C. Davis. (2016) Functional outcome and complications following surgery for Dupuytren’s disease: a multi-centre cross-sectional study. Journal of Hand Surgery (European Volume) 42:1, pages 7-17.
Crossref
Maarten Van Nuffel & Ilse Degreef. 2017. Dupuytren Disease and Related Diseases - The Cutting Edge. Dupuytren Disease and Related Diseases - The Cutting Edge 291 297 .
David Warwick. 2017. Dupuytren Disease and Related Diseases - The Cutting Edge. Dupuytren Disease and Related Diseases - The Cutting Edge 199 203 .
J. Rodrigues, W. Zhang, B. Scammell, P. Russell, I. Chakrabarti, S. Fullilove, D. Davidson & T. Davis. (2015) Validity of the Disabilities of the Arm, Shoulder and Hand patient-reported outcome measure (DASH) and the Quickdash when used in Dupuytren’s disease. Journal of Hand Surgery (European Volume) 41:6, pages 589-599.
Crossref
Jack Bradley & David Warwick. (2016) Patient Satisfaction With Collagenase. The Journal of Hand Surgery 41:6, pages 689-697.
Crossref
Christina Engstrand, Barbro Krevers & Joanna Kvist. (2015) Factors affecting functional recovery after surgery and hand therapy in patients with Dupuytren's disease. Journal of Hand Therapy 28:3, pages 255-260.
Crossref
Nancy J Forget, Christina Jerosch-Herold, Lee Shepstone & Johanne Higgins. (2014) Psychometric evaluation of the Disabilities of the Arm, Shoulder and Hand (DASH) with Dupuytren’s contracture: validity evidence using Rasch modeling. BMC Musculoskeletal Disorders 15:1.
Crossref
Charles Eaton. (2014) Evidence-Based Medicine. Plastic and Reconstructive Surgery 133:5, pages 1241-1251.
Crossref
Ilse Degreef, Sabine Tejpar, Raf Sciot & Luc De Smet. (2014) High-Dosage Tamoxifen as Neoadjuvant Treatment in Minimally Invasive Surgery for Dupuytren Disease in Patients with a Strong Predisposition Toward Fibrosis. Journal of Bone and Joint Surgery 96:8, pages 655-662.
Crossref
N. Ferry, G. Lasserre, J. Pauchot, D. Lepage & Y. Tropet. (2013) Particularités de la maladie de Dupuytren chez la femme. À propos de 67 cas. Annales de Chirurgie Plastique Esthétique 58:6, pages 663-669.
Crossref
Steven Lo & Mark Pickford. (2012) Current concepts in Dupuytren’s disease. Current Reviews in Musculoskeletal Medicine 6:1, pages 26-34.
Crossref
C. Dumontier, M. Soubeyrand & S. Carmès. 2013. Orthopédie-traumatologie de la personne âgée fragile. Orthopédie-traumatologie de la personne âgée fragile 237 247 .
David Warwick, Alexis Thomas & Ardeshir Bayat. (2012) Dupuytren’s disease: overview of a common connective tissue disease with a focus on emerging treatment options. International Journal of Clinical Rheumatology 7:3, pages 309-323.
Crossref
Christina Jerosch-Herold, Lee Shepstone, Adrian J. Chojnowski & Debbie Larson. 2012. Dupuytren’s Disease and Related Hyperproliferative Disorders. Dupuytren’s Disease and Related Hyperproliferative Disorders 317 321 .
Ilse Degreef. 2012. Dupuytren’s Disease and Related Hyperproliferative Disorders. Dupuytren’s Disease and Related Hyperproliferative Disorders 255 260 .
Ilse Degreef & Luc De Smet. 2012. Dupuytren’s Disease and Related Hyperproliferative Disorders. Dupuytren’s Disease and Related Hyperproliferative Disorders 207 211 .
Johann Beaudreuil, Anne Allard, Djamila Zerkak, Robert A. Gerber, Joseph C. Cappelleri, Nathaly Quintero, Sandra Lasbleiz, Brigitte Bernabé, Philippe Orcel & Thomas Bardin. (2011) Unité Rhumatologique des Affections de la Main (URAM) scale: Development and validation of a tool to assess Dupuytren's disease–specific disability. Arthritis Care & Research 63:10, pages 1448-1455.
Crossref
Karsten Knobloch, Marie Kuehn, Stephan Papst, Robert Kraemer & Peter M. Vogt. (2011) German Standardized Translation of the Michigan Hand Outcomes Questionnaire for Patient-Related Outcome Measurement in Dupuytren Disease. Plastic and Reconstructive Surgery 128:1, pages 39e-40e.
Crossref
Christina Jerosch-Herold, Lee Shepstone, Adrian Chojnowski & Debbie Larson. (2011) Severity of Contracture and Self-reported Disability in Patients with Dupuytren’s Contracture Referred for Surgery. Journal of Hand Therapy 24:1, pages 6-11.
Crossref
Karsten Knobloch, Joern Redeker & Peter M. Vogt. (2009) Antifibrotic medication using a combination of N-acetyl-L-cystein (NAC) and ACE inhibitors can prevent the recurrence of Dupuytren’s disease. Medical Hypotheses 73:5, pages 659-661.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.